E-drug: Nevirapine donation
---------------------------------------------
The German company Boehringer-Ingelheim promised since the AIDS
conference in Durban (July 2000) to donate Nevirapine for the
prevention of mother to child transmission (MTCT) of HIV to
developing countries. We
would like to know how much the drug donation has materialised. We would
appreciate responses from countries where the donation was accepted (or
refuted), the scale and conditions of the donation and whether the donation
was perceived as useful contribution to the health system (or not)
BUKO Pharma-Kampagne is monitering the conduct of the German
pharmaceutical industry in developing countries.
From,
Gopal Dabade/Jorg Schaaber
BUKO Pharma-Kampagne,
August Bebel Str 62,
D-33602 Bielefeld,
Germany
BUKO Pharma-Kampagne <bukopharma@compuserve.com>
Web page www.bukopharma.de
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: owner-e-drug@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html